A Natural Model of Leishmania major Infection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity

A model of Leishmania major infection in C57BL/6 mice has been established that combines two main features of natural transmission: low dose (100 metacyclic promastigotes) and inoculation into a dermal site (the ear dermis). The evolution of the dermal lesion could be dissociated into two distinct phases. The initial “silent” phase, lasting 4–5 wk, favored establishment of the peak load of parasites in the dermis in the absence of lesion formation or any overt histopathologic changes in the site. The second phase corresponds to the development of a lesion associated with an acute infiltration of neutrophils, macrophages, and eosinophils into the dermis and was coincident with the killing of parasites in the site. The onset of immunity/pathology was correlated with the appearance of cells staining for IL-12p40 and IFN-γ in the epidermal compartment, and an expansion of T cells capable of producing IFN-γ in the draining lymph node. Parasite growth was not enhanced over the first 4.5 wk in anti-CD4-treated mice, SCID mice, or C57BL/6 mice deficient in IL-12p40, IFN-γ, CD40 ligand, or inducible NO synthase. These mice all failed to ultimately control infection in the site, but in some cases (anti-CD4 treated, IL-12p40−/−, CD40 ligand−/−, and SCID) high dermal parasite loads were associated with little or no pathology. These results extend to a natural infection model a role for Th1 cells in both acquired resistance and lesion formation, and document the remarkable avoidance of this response during a prolonged phase of parasite amplification in the skin.

[1]  T. Theander,et al.  Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. , 1999, Clinical immunology.

[2]  A. Stagg,et al.  Murine dendritic cells internalize Leishmania major promastigotes, produce IL‐12 p40 and stimulate primary T cell proliferation in vitro , 1999, European journal of immunology.

[3]  W. Paul,et al.  IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. , 1999, Journal of immunology.

[4]  N. Glaichenhaus,et al.  Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites , 1999, European journal of immunology.

[5]  M. Roncarolo,et al.  A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. , 1999, Journal of immunology.

[6]  G. Feng,et al.  Regulation of macrophage IL‐12 synthesis by Leishmania phosphoglycans , 1999, European journal of immunology.

[7]  Y. Belkaid,et al.  Development of a Natural Model of Cutaneous Leishmaniasis: Powerful Effects of  Vector Saliva and Saliva Preexposure on the Long-Term Outcome of Leishmania major Infection in the Mouse Ear Dermis , 1998, The Journal of experimental medicine.

[8]  Yasmine Belkaid,et al.  Uptake of Leishmania major Amastigotes Results in Activation and Interleukin 12 Release from Murine Skin–derived Dendritic Cells: Implications for the Initiation of Anti-Leishmania Immunity , 1998, The Journal of experimental medicine.

[9]  Yasmine Belkaid,et al.  Analysis of cytokine production by inflammatory mouse macrophages at the single‐cell level: selective impairment of IL‐12 induction in Leishmania ‐infected cells , 1998, European journal of immunology.

[10]  Elio Cenci,et al.  Endogenous Interleukin 4 Is Required for Development of Protective Cd4 Ϩ T Helper Type 1 Cell Responses to Candida Albicans , 1998 .

[11]  P. Kaye,et al.  Dendritic cells, but not macrophages, produce IL‐12 immediately following Leishmania donovani infection , 1998, European journal of immunology.

[12]  J. Shaw,et al.  Experimental cutaneous leishmaniasis. IV. The humoral response of Cebus apella (Primates: Cebidae) to infections of Leishmania (Leishmania) amazonensis, L. (Viannia) lainsoni and L. (V.) braziliensis using the direct agglutination test. , 1997, Acta tropica.

[13]  G. Trinchieri,et al.  Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. , 1997, Journal of immunology.

[14]  J. Sun,et al.  Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. , 1997, Journal of immunology.

[15]  P. Bergstresser,et al.  Cytokine-mediated communication by keratinocytes and Langerhans cells with dendritic epidermal T cells. , 1996, Seminars in immunology.

[16]  D. Mcmahon-Pratt,et al.  Leishmania‐infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells , 1996, European journal of immunology.

[17]  H. Bluethmann,et al.  Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response. , 1996, Immunobiology.

[18]  C. Bogdan,et al.  Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase , 1996, The Journal of experimental medicine.

[19]  S. Reed,et al.  CD40 ligand is required for protective cell-mediated immunity to Leishmania major. , 1996, Immunity.

[20]  C. Roberts,et al.  Different roles for interleukin-4 during the course of Toxoplasma gondii infection , 1996, Infection and immunity.

[21]  T. Horii,et al.  Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. , 1996, Immunity.

[22]  R. Badolato,et al.  Promastigotes Selectively Inhibit Interleukin 12 Induction in Bone Marrow-derived Macrophages from Susceptible and Resistant Mice , 1996 .

[23]  Y. Belkaid,et al.  A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. , 1996, Journal of immunological methods.

[24]  H. Macdonald,et al.  In susceptible mice, Leishmania major induce very rapid interleukin‐4 production by CD4+ T cells which are NK1.1− , 1995, European journal of immunology.

[25]  N. Ganguly,et al.  Macrophage‐T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania‐infected macrophages and its implication in the suppression of cell‐mediated immunity , 1995, European journal of immunology.

[26]  M. Belosevic,et al.  Response of scid mice to establishment of Leishmania major infection , 1995, Clinical and experimental immunology.

[27]  L. Glimcher,et al.  Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. , 1995, The Journal of infectious diseases.

[28]  T. Theander,et al.  The pathology of cutaneous leishmaniasis due to Leishmania major in Sudan. , 1995, The American journal of tropical medicine and hygiene.

[29]  P. Scott,et al.  The role of the innate immune response in Th1 cell development following Leishmania major infection , 1995, Journal of leukocyte biology.

[30]  M. Röllinghoff,et al.  Dendritic cells in Leishmania major‐immune mice harbor persistent parasites and mediate an antigen‐specific T cell immune response , 1995, European journal of immunology.

[31]  T. Theander,et al.  Antigen‐presenting cells in human cutaneous leishmaniasis due to Leishmania major , 1995, Clinical and experimental immunology.

[32]  P. Kaye,et al.  Deficient expression of co‐stimulatory molecules on Leishmania‐infected macrophages , 1994, European journal of immunology.

[33]  C. Bogdan,et al.  Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major , 1994, The Journal of experimental medicine.

[34]  G. Trinchieri,et al.  Infection with Leishmania major induces interleukin-12 production in vivo. , 1994, Immunology letters.

[35]  R. Locksley,et al.  Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection , 1994, The Journal of experimental medicine.

[36]  J. Guillet,et al.  Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. , 1993, Journal of immunology.

[37]  M. Röllinghoff,et al.  Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen‐specific T cells , 1993, European journal of immunology.

[38]  R. Schaub,et al.  Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.

[39]  R. Rerko,et al.  Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.

[40]  E. Handman,et al.  Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host , 1993, Infection and immunity.

[41]  A. Kelso,et al.  Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis. , 1992, Journal of immunology.

[42]  M. Röllinghoff,et al.  Murine epidermal Langerhans cells are potent stimulators of an antigen‐specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis , 1992, European journal of immunology.

[43]  R. Coffman,et al.  IL-4 induces a Th2 response in Leishmania major-infected mice. , 1992, Journal of immunology.

[44]  M. Belosevic,et al.  Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. , 1989, Journal of immunology.

[45]  N. Reiner,et al.  Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. , 1987, Journal of immunology.

[46]  R. Pearson,et al.  Early histopathology of experimental infection with Leishmania donovani in hamsters. , 1987, The Journal of parasitology.

[47]  Y. Schlein,et al.  The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. , 1986, The American journal of tropical medicine and hygiene.

[48]  T. Boon,et al.  A limiting dilution assay for quantifying Leishmania major in tissues of infected mice , 1985, Parasite immunology.

[49]  J. Convit,et al.  In situ characterization of the cellular immune response in American cutaneous leishmaniasis. , 1985, Clinical and experimental immunology.

[50]  J. O. Hill Resistance to cutaneous leishmaniasis: acquired ability of the host to kill parasites at the site of infection , 1984, Infection and immunity.

[51]  R. Locksley,et al.  Development of cellular immunity in cutaneous leishmaniasis due to Leishmania tropica. , 1984, The Journal of infectious diseases.

[52]  R. North,et al.  Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis , 1983, Infection and immunity.

[53]  C. Hale,et al.  Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. , 1982, Journal of immunology.

[54]  H. Rey Cellular Reactions in the Dermal Connective Tissue of the Hamster to Leishmania brasiliensis. , 1943 .

[55]  C. Bogdan,et al.  Type 1 Interferon (IFNα/β) and Type 2 Nitric Oxide Synthase Regulate the Innate Immune Response to a Protozoan Parasite , 1998 .

[56]  H. Moll,et al.  Dendritic cells seclude Leishmania parasites that persist in cured mice--a role in the maintenance of T-cell memory? , 1995, Advances in experimental medicine and biology.

[57]  P. Vassalli,et al.  Involvement of specific Lyt‐2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis , 1987, European journal of immunology.

[58]  D. Dumonde,et al.  Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. , 1976, Clinical and experimental immunology.